163 related articles for article (PubMed ID: 25039933)
1. Improvement of national blood safety profile: effect of contract fractionation of plasma in resource limited countries, the Moroccan experience.
Boulahdid S; Benahadi A; Adouani B; Laouina A; Mehdaoui FE; Mokhtari A; Soulaymani A; Hajjout K; Alami R
Haemophilia; 2014 Sep; 20(5):e359-62. PubMed ID: 25039933
[No Abstract] [Full Text] [Related]
2. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines.
Cheraghali AM; Aboofazeli R
Transfus Med; 2009 Dec; 19(6):363-8. PubMed ID: 19778319
[TBL] [Abstract][Full Text] [Related]
3. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
[No Abstract] [Full Text] [Related]
4. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
Cheraghali AM; Abolghasemi H
Haemophilia; 2009 Mar; 15(2):487-93. PubMed ID: 19347989
[TBL] [Abstract][Full Text] [Related]
5. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
Josephson CD; Abshire TC
Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
[TBL] [Abstract][Full Text] [Related]
6. Blood banking and transfusion medicine in extreme or resource-limited conditions.
Nollet KE
Transfus Apher Sci; 2013 Dec; 49(3):378-9. PubMed ID: 24095641
[No Abstract] [Full Text] [Related]
7. Public policy, blood safety and haemovigilance.
Roberts DJ
Transfus Med; 2011 Dec; 21(6):357-8. PubMed ID: 22082175
[No Abstract] [Full Text] [Related]
8. Transfusion reactions: a comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood.
Semple E; Bowes-Schmidt A; Yi QL; Shimla S; Devine DV
Transfusion; 2012 Dec; 52(12):2683-91. PubMed ID: 22738255
[TBL] [Abstract][Full Text] [Related]
9. [Substitution therapy of hemorrhagic diseases].
Haupt H
Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
[No Abstract] [Full Text] [Related]
10. [Letter: Treatment of patients with hemorrhagic disease--hemophilia].
Arnoldi CC; Bessermann-Nielsen M; Gormsen J; Krogh-Jensen M; Mohr J; Plum P; Sjolin KE; Zachariae E; Jorgensen J
Ugeskr Laeger; 1974 Nov; 136(48):2694-5. PubMed ID: 4439510
[No Abstract] [Full Text] [Related]
11. [The treatment of inherited coagulation disorders].
Blombäck M; Nilsson IM
Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
[No Abstract] [Full Text] [Related]
12. The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story.
Flesland O; Seghatchian J; Solheim BG
Transfus Apher Sci; 2003 Feb; 28(1):93-100. PubMed ID: 12620274
[TBL] [Abstract][Full Text] [Related]
13. Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.
Wiersum-Osselton JC; Faber JC; Politis C; Brand A; van der Bom JG; Schipperus MR
Vox Sang; 2013 Apr; 104(3):214-7. PubMed ID: 23061879
[TBL] [Abstract][Full Text] [Related]
14. Risk-based decision-making for blood safety: preliminary report of a consensus conference.
Stein J; Besley J; Brook C; Hamill M; Klein E; Krewski D; Murphy G; Richardson M; Sirna J; Skinner M; Steiner R; van Aken P; Devine D
Vox Sang; 2011 Nov; 101(4):277-81. PubMed ID: 21781125
[No Abstract] [Full Text] [Related]
15. AABB contributions to plasma safety.
Triulzi DJ
Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
[No Abstract] [Full Text] [Related]
16. Innovations in coagulation: improved options for treatment of hemophilia A and B.
Pabinger-Fasching I; Pipe S
Thromb Res; 2013 Mar; 131 Suppl 2():S1. PubMed ID: 23537720
[No Abstract] [Full Text] [Related]
17. Only screen blood or safe blood management.
Irfan M
J Pak Med Assoc; 2000 Nov; 50(11):368-9. PubMed ID: 11126811
[No Abstract] [Full Text] [Related]
18. The use of blood fractions in coagulation disorders.
Biggs R
Br J Haematol; 1969 Dec; 17(6):604. PubMed ID: 5357747
[No Abstract] [Full Text] [Related]
19. Introduction.
Shander A
Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):1-3. PubMed ID: 23590910
[No Abstract] [Full Text] [Related]
20. [Drug use in blood donors].
Berg JA; Schjøtt J
Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
